The Case Comprehensive Cancer Center
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1826-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.case.edu/cancer
Positron Emission Tomography Using Fludeoxyglucose F 18 in Predicting Response to Treatment in Patients Who Are Receiving Rituximab and Combination Chemotherapy for Newly Diagnosed Non-Hodgkin's Lymphoma
- Conditions
- Lymphoma
- First Posted Date
- 2005-05-04
- Last Posted Date
- 2010-06-11
- Lead Sponsor
- Case Comprehensive Cancer Center
- Registration Number
- NCT00110006
Photodynamic Therapy Using Silicon Phthalocyanine 4 in Treating Patients With Actinic Keratosis, Bowen's Disease, Skin Cancer, or Stage I or Stage II Mycosis Fungoides
- Conditions
- LymphomaNon-melanomatous Skin CancerPrecancerous Condition
- Interventions
- First Posted Date
- 2005-02-08
- Last Posted Date
- 2019-01-22
- Lead Sponsor
- Case Comprehensive Cancer Center
- Target Recruit Count
- 43
- Registration Number
- NCT00103246
- Locations
- 🇺🇸
Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States
Liposomal Doxorubicin in Treating Patients With Prostate Cancer
- Conditions
- Prostate Cancer
- First Posted Date
- 2004-09-14
- Last Posted Date
- 2010-08-16
- Lead Sponsor
- Case Comprehensive Cancer Center
- Target Recruit Count
- 10
- Registration Number
- NCT00004014
- Locations
- 🇺🇸
Ireland Cancer Center at University Hospitals Case Medical Center, Cleveland, Ohio, United States
Irinotecan in Treating Patients With Metastatic or Recurrent Colorectal Cancer
- Conditions
- Colorectal Cancer
- First Posted Date
- 2004-08-12
- Last Posted Date
- 2020-07-27
- Lead Sponsor
- Case Comprehensive Cancer Center
- Target Recruit Count
- 21
- Registration Number
- NCT00002933
- Locations
- 🇺🇸
Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States
🇺🇸Veterans Affairs Medical Center - Cleveland, Cleveland, Ohio, United States
O(6)-Benzylguanine and Carmustine in Treating Patients With Solid Tumors
- Conditions
- Unspecified Adult Solid Tumor, Protocol Specific
- First Posted Date
- 2004-07-29
- Last Posted Date
- 2010-07-08
- Lead Sponsor
- Case Comprehensive Cancer Center
- Target Recruit Count
- 28
- Registration Number
- NCT00002604
- Locations
- 🇺🇸
Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States
🇺🇸Veterans Affairs Medical Center - Cleveland, Cleveland, Ohio, United States
Combination Chemotherapy in Treating Patients With Recurrent or Refractory Leukemia
- Conditions
- Leukemia
- First Posted Date
- 2004-07-29
- Last Posted Date
- 2010-06-11
- Lead Sponsor
- Case Comprehensive Cancer Center
- Target Recruit Count
- 30
- Registration Number
- NCT00002588
- Locations
- 🇺🇸
Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States
Chemotherapy, Filgrastim, and Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
- Conditions
- Lymphoma
- First Posted Date
- 2004-07-26
- Last Posted Date
- 2012-03-20
- Lead Sponsor
- Case Comprehensive Cancer Center
- Registration Number
- NCT00003929
- Locations
- 🇺🇸
Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States
Topotecan in Treating Patients With Recurrent Extensive-Stage Small Cell Lung Cancer
- Conditions
- Lung Cancer
- First Posted Date
- 2004-07-12
- Last Posted Date
- 2016-03-22
- Lead Sponsor
- Case Comprehensive Cancer Center
- Target Recruit Count
- 1
- Registration Number
- NCT00087048
- Locations
- 🇺🇸
Josephine Ford Cancer Center at Henry Ford Hospital, Detroit, Michigan, United States
🇺🇸Case Comprehensive Cancer Center, Cleveland, Ohio, United States
Interferon Beta in Treating Patients With Metastatic Cutaneous Melanoma or Ocular Melanoma
- Conditions
- Recurrent MelanomaStage IV Melanoma
- First Posted Date
- 2004-06-11
- Last Posted Date
- 2015-10-02
- Lead Sponsor
- Case Comprehensive Cancer Center
- Target Recruit Count
- 21
- Registration Number
- NCT00085306
- Locations
- 🇺🇸
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland, Ohio, United States
Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer
- Conditions
- Lung Cancer
- First Posted Date
- 2004-06-09
- Last Posted Date
- 2014-01-15
- Lead Sponsor
- Case Comprehensive Cancer Center
- Registration Number
- NCT00006374